This inventor holds 1 USPTO granted patent. Top assignee: Eisai R&D Management Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yuki Karoji: Inventor in Pharmaceutical Process Development.
Introduction
Yuki Karoji is an inventor associated with Kamisu, Japan, and Eisai R&D Management Co., Ltd. Her work includes a patented production method for an intermediate used in the development of E7090, an FGFR inhibitor.
Latest Patents
Karoji is named on one patent, titled “Production Method for Synthetic Intermediate of Monocyclic Pyridine Derivative.” The invention describes a process intended to enable higher-yield and more efficient synthesis of key intermediates—compound (2i) or a salt thereof, and compound (1g)—for producing E7090. Her patent portfolio includes 1 patent.
Career Highlights
Karoji’s listed invention concerns pharmaceutical manufacturing, specifically the synthesis of intermediates used in producing a compound with FGFR-inhibiting activity. The available information identifies her as an inventor associated with Eisai R&D Management Co., Ltd.
Collaborations
Karoji’s named coworkers include Mitsuo Nagai and Takashi Fukuyama. Their shared patent work reflects collaboration on a production process for a synthetic intermediate.
Conclusion
Yuki Karoji’s patent highlights her contribution to developing a more efficient synthesis route for intermediates used in the production of E7090.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile